Ocular Therapeutix shares jumped 13% in premarket trading after reports said Sanofi is preparing a takeover offer. The renewed interest follows OCUL rejection of Sanofi $16-per-share bid last September. A deal would strengthen Sanofi ophthalmology presence, even as OCUL shares have recently been under pressure.